4 completed, 2 unknown, 1 suspended, 1 withdrawn. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 4, Unknown 2, Suspended 1, Withdrawn 1 |
Follow Extravasation of Diagnostic and Therapeutic Materials: new trials by email Literature Review of Extravasation of Diagnostic and Therapeutic Materials trials Research Report on Extravasation of Diagnostic and Therapeutic Materials
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Simultaneous mRNA COVID-19 and IIV4 Vaccination Study mRNA COVID-19, IIV4, Placebo (saline) - Quality of Life, Injection Site Reaction | Phase 4 | Completed | Duke University | 348 | 2021-10-04 | 2024-03-19 |
| Simultaneous RZV and aIIV4 Vaccination FLUAD® Quadrivalent, Fluzone® High-Dose Quadrivalent, SHINGRIX® - Pain, Quality of Life | Phase 4 | Completed | Duke University | 267 | 2021-09-21 | 2024-07-11 |
| Naldebain and Video-assisted Thoracoscopic Surgery Nalbuphine Sebacate or Sesame oil (placebo) - Analgesia, Nausea and Vomiting, Postoperative | Phase 4 | Unknown | Kaohsiung Medical University Chung-Ho Memorial Hospital | 60 | 2021-07-07 | 2024-03-21 |
| Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects Plegridy, Prednisone, Tylenol Pill - Multiple Sclerosis | Phase 4 | Unknown | Holy Name Medical Center, Inc. | 50 | 2017-09-25 | 2019-08-15 |
| FLUAD® vs. Fluzone® High-Dose Study FLUAD®, Fluzone® High-Dose - Pain, Quality of Life | Phase 4 | Completed | Duke University | 757 | 2017-08-28 | 2021-03-30 |
| A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers. Sodium chloride - Injection Site Reaction | Phase 4 | Completed | Aspen Global Incorporated | 15 | 2016-06-02 | 2019-02-15 |
| Brimonidine Tartrate for the Treatment of Injection Related Erythema peginterferon beta-1a, brimonidine tartrate, Vehicle Gel - Relapsing-Remitting Multiple Sclerosis (RRMS) | Phase 4 | Withdrawn | Biogen | 2016-02-01 | 2016-04-25 | |
| Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children 0,9% NaCl flush, Heparin 50U/ml - Infection of Intravenous Catheter, Phlebitis | Phase 4 | Suspended | University of Florence | 52 | 2013-01-01 | 2015-10-29 |
Injection Site Reaction (7) · Drug-Related Side Effects and Adverse Reactions (3) · Influenza, Human (3) · Pain (2) · Agnosia (1) · COVID-19 (1) · Demyelinating Diseases (1) · Erythema (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Patient Satisfaction (1) · Phlebitis (1) · Postoperative Nausea and Vomiting (1) · Pruritus (1)
Pathologic Processes (8) · Pathological Conditions, Signs and Symptoms (8) · Chemically-Induced Disorders (7) · Drug-Related Side Effects and Adverse Reactions (4) · Signs and Symptoms (4) · Infections (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Orthomyxoviridae Infections (3) · RNA Virus Infections (3) · Respiratory Tract Diseases (3) · Respiratory Tract Infections (3) · Virus Diseases (3) · Autoimmune Diseases (2)
Influenza Vaccines (2) · Sodium Chloride (2) · peginterferon beta-1a (2) · 2019-nCoV Vaccine mRNA-1273 (1) · Acetaminophen (1) · Brimonidine Tartrate (1) · Heparin (1) · Prednisone (1) · Saline Solution (1) · Sesame Oil (1) · fluad vaccine (1)
Duke University (3) · Aspen Global Incorporated (1) · Biogen (1) · Holy Name Medical Center, Inc. (1) · Kaohsiung Medical University Chung-Ho Memorial Hospital (1) · University of Florence (1)
United States (4) · Italy (1) · Taiwan (1)
Kenneth Schmader, MD (2) · Elizabeth Barnett, MD (1) · Elizabeth Schlaudecker, MD, MPH (1) · Emmanuel B Walter, MD, MPH (1) · Filippo Festini, RN, BSN, MSN (1) · Hung-Te Hsu, MD, PhD (1) · Karen R Broder, MD (1) · Kawsar Talaat, MD (1) · Theresa Harrington, MD (1)
PMID 15304586, PMID 17588298, PMID 33443580, PMID 37393237, PMID 37781954, PMID 39446325, PMID 39504023, PMID 40382572, PMID 41380398, PMID 9633761
2015 (1)